John Hancock

John Hancock is a corporate partner with principal concentration on the securities matters involved in corporate financing transactions (both public offerings and private placements) and mergers and acquisitions. He represents clients in a variety of industries, but has a particular focus on high technology, software and medical device companies. John serves as Co-Chair of the firm's Capital Markets Practice.

Recent Posts by John Hancock:

• The SEC Continues its Efforts to Improve Option Grant Practices
• “Finders” Operating in Massachusetts Should Beware the SEC’s Proposed Relief
• New law aimed at US-listed Chinese companies may impact other public companies with Chinese operations
• SEC Brings First Enforcement Action Against Issuer for Disclosures About Financial Effects of COVID-19
• SEC Targets Issuers and Officers for Disclosure Violations Through Data Analytics
• SEC Revises Financial Statement Disclosure Requirements for Acquisitions and Dispositions
• Nasdaq Provides Limited Relief to Facilitate Near-Term Capital Raising
• SEC Extends Conditional Relief for Exchange Act Filings to July 1, 2020
• SEC gives Issuers Added Flexibility to Adjust Annual Meetings in Light of COVID-19
• New ISS voting guidelines ramp up expectations for public companies